Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Victor L. Serebruany"'
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 28(1)
Clopidogrel response variability (CRV) is well documented, and may affect clinical outcomes. Impact of genetic polymorphisms is important for assessing and predicting CRV. The extensive evidence indicates the importance of CYP2C19 variants in reducin
Autor:
Mustafa Hakan Dinçkal, Ilhan Iker Avci, Irfan Sahin, Ahmet Karabulut, Ertugrul Okuyan, Mehmet Mustafa Can, Victor L. Serebruany, Süleyman Sezai Yıldız, Barış Güngör, Halil İbrahim Biter
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 26(3)
Contrast-induced nephropathy (CIN) accounts for 10% of hospital-acquired renal failure, causes a prolonged in-hospital stay and represents a powerful predictor of poor clinical outcome. The underlying mechanism of the CIN development remains unclear
Autor:
Benjamin Oshrine, Dan Atar, Marcus E. McKenzie, Victor L. Serebruany, Christopher R. Bell, Eric D. Horowitz, Alex Dzhanashvili, Alex I. Malinin
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 14(3)
Platelet inhibition after aspirin therapy reduces the risk for the development of acute coronary syndromes. However, the mechanism by which aspirin affect platelets other than by prostaglandin blockade is unclear. We sought to determine the in vitro